Clearside Biomedical Inc (CLSD) Stock Analysis

Clearside Biomedical Inc (CLSD) is a publicly traded company in the HEALTHCARE sector. It trades at $0.41. This page summarizes the public market data, fundamentals, and frequently asked questions for CLSD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Clearside Biomedical Inc currently has a Bullish sentiment score of 0.49.

About Clearside Biomedical Inc

Clearside Biomedical, Inc. is a biopharmaceutical company based in Alpharetta, Georgia, dedicated to developing innovative therapies aimed at restoring and preserving vision for patients with serious ocular diseases. The company's proprietary SCS Microinjector technology enables targeted drug delivery, enhancing the treatment efficacy for conditions such as uveitis and macular edema. With a promising pipeline and strategic collaborations, Clearside is well-positioned to address critical unmet...

GNG Research Analysis

GNG Research scores Clearside Biomedical Inc (CLSD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CLSD.

Frequently Asked Questions

Does CLSD pay dividends?

Clearside Biomedical Inc (CLSD) does not currently pay a regular dividend.